Glioblastoma (GBM) is the most aggressive malignant brain tumor and is associated with a
very poor prognosis. The standard treatment for newly diagnosed patients involves total …

Glioblastoma (GBM) is a particularly aggressive brain cancer associated with high
recurrence and poor prognosis. The standard of care, surgical resection followed by …

Glioma is one of the most common type of malignant tumours with high morbidity and
mortality rates. Due to the particular features of the brain, such as blood–brain barrier or …

Glioblastoma (GBM) is an aggressive malignant cancer associated with bleak prognosis and
high mortality. The current standard of care for GBM is maximum surgical resection plus …

Malignant gliomas, including glioblastoma and anaplastic astrocytomas, are characterized
by their propensity to invade surrounding brain parenchyma, making curative resection …

Malignant gliomas (MGs) are the most common and devastating primary brain tumor. At
present, surgical interventions, radiotherapy, and chemotherapy are only marginally …

Among central nervous system tumors, Glioblastoma (GBM) is the most common, aggressive
and neurological destructive primary brain tumor in adults. Standard care therapy for GBM …

The therapy of brain tumors has been limited by a lack of effective methods of drug delivery
to the brain. Systemic administration is often associated with toxic side effects and ultimately …

Glioblastoma is one of the most aggressive brain tumors and is associated with a very low
overall median survival despite the current treatment. The standard of care used in clinic is …

Glioblastoma multiforme (GBM) is a brain tumor notorious for its malignancy. The key reason
for the limited efficacy of standard treatment is the high recurrence rate of GBM, even after …